Hishimo Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 05-07-2024
- Paid Up Capital ₹ 20.00 K
as on 05-07-2024
- Company Age 32 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 10.85 Cr
as on 05-07-2024
- Revenue 229.97%
(FY 2023)
- Profit 1903.11%
(FY 2023)
- Ebitda 1387.70%
(FY 2023)
- Net Worth 148.58%
(FY 2023)
- Total Assets -9.14%
(FY 2023)
About Hishimo Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 20.00 K .
The company currently has active open charges totaling ₹10.85 Cr.
Mohit Bhatnagar, Kanishk Bhatnagar, and Teena Bhatnagar serve as directors at the Company.
- CIN/LLPIN
U24232RJ1992PTC006718
- Company No.
006718
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 1992
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Hishimo Pharmaceuticals Private Limited offer?
Hishimo Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine, Antiviral Drugs, Ayurvedic Treatment, Kidney Stone Ayurvedic Treatment, Ayurvedic Cough & Cold Medicine, Child and Baby Care Products, Baby Care Products, Digestive System Drugs & Medicines, Gastrointestinal Drugs.
Who are the key members and board of directors at Hishimo Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohit Bhatnagar  | Director | 19-Aug-2009 | Current |
| Kanishk Bhatnagar | Director | 27-Jan-2024 | Current |
| Teena Bhatnagar | Director | 28-Apr-2015 | Current |
Financial Performance of Hishimo Pharmaceuticals.
Hishimo Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 229.97% increase. The company also saw a substantial improvement in profitability, with a 1903.11% increase in profit. The company's net worth Soared by an impressive increase of 148.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hishimo Pharmaceuticals?
In 2023, Hishimo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Jan 2024 | ₹3.50 Cr | Open |
Others Creation Date: 20 Jan 2024 | ₹6.50 Cr | Open |
Axis Bank Limited Creation Date: 08 Sep 2023 | ₹8.47 M | Open |
How Many Employees Work at Hishimo Pharmaceuticals?
Unlock and access historical data on people associated with Hishimo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hishimo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hishimo Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
